Explore Profiles of the World’s Best Equity Research Analysts
| Name | Main Sector |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Latest Rating | |
|---|---|---|---|---|---|---|
|
LI
301
Luca Issi
RBC Capital
| Healthcare | 48 | +20% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
JG
302
Jason Goldberg
Barclays
| Financials | 48 | +9.6% |
0
%
| 26 Jan ‘26 3 months ago |
|
|
JR
303
Joseph Reagor
Roth Capital
| Materials | 38 | +19% |
0
%
| 24 Feb ‘26 2 months ago |
|
|
EK
304
Eddie Kim
Barclays
| Energy | 38 | +6.3% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
AM
305
Andre Madrid
BTIG
| Industrials | 36 | +5.1% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
MF
306
Mark Fitzgibbon
Piper Sandler
| Financials | 27 | +4.5% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
TL
307
Tal Liani
BofA Securities
| Technology | 21 | +2.2% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
DA
308
Doug Anmuth
JP Morgan
| Communication Services | 94 | +2% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
BL
309
Brian Lee
Goldman Sachs
| Technology | 55 | +18% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
AS
310
Ashish Sabadra
RBC Capital
| Financials | 46 | +3.3% |
0
%
| 26 Feb ‘26 2 months ago |
|
|
ML
311
Michael Leshock
Keybanc
| Industrials | 27 | +17% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
SK
312
Sumant Kulkarni
Canaccord Genuity
| Healthcare | 23 | +14% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
JZ
313
Jeffrey Zekauskas
JP Morgan
| Materials | 78 | +16% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
HK
314
Hamed Khorsand
BWS Financial
| Technology | 94 | +7.3% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
SR
315
Swayampakula Ramakanth
HC Wainwright & Co
| Healthcare | 107 | +34% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
FF
316
Filippo Falorni
Citigroup
| Consumer Staples | 79 | +1.8% |
0
%
| 25 Feb ‘26 2 months ago |
|
|
SS
317
Seth Seifman
JP Morgan
| Industrials | 57 | +4.2% |
0
%
| 23 Feb ‘26 2 months ago |
|
|
DK
318
David Konrad
Keefe, Bruyette & Woods
| Financials | 56 | +7.6% |
0
%
| 6 Feb ‘26 2 months ago |
|
|
JH
319
Jason Helfstein
Oppenheimer
| Communication Services | 51 | +0.43% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
RB
320
Ryan Brinkman
JP Morgan
| Consumer Discretionary | 49 | +4% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
BK
321
Ben Kallo
Baird
| Consumer Discretionary | 43 | +24% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
DT
322
David Tarantino
Baird
| Consumer Discretionary | 41 | +3.3% |
0
%
| 27 Feb ‘26 1 month ago |
|
323
Alexander Potter
Piper Sandler
| Consumer Discretionary | 41 | -0.56% |
0
%
| 13 Feb ‘26 2 months ago |
|
|
MC
324
Mark Carden
UBS
| Consumer Staples | 40 | +1.8% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
DA
325
David Amsellem
Piper Sandler
| Healthcare | 40 | +0.73% |
0
%
| 4 Mar ‘26 1 month ago |
|